Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/102874
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling
Author: Wang, X.
da Mota, S.
Liu, R.
Moore, C.
Xie, J.
Lanucara, F.
Agarwala, U.
Ruys, S.
Vertommen, D.
Rider, M.
Eyers, C.
Proud, C.
Citation: Molecular and Cellular Biology, 2014; 34(22):4088-4103
Publisher: American Society for Microbiology
Issue Date: 2014
ISSN: 0270-7306
1098-5549
Statement of
Responsibility: 
Xuemin Wang, Sergio Regufe da Mota, Rui Liu, Claire E. Moore, Jianling Xie, Francesco Lanucara, Usha Agarwala, Sébastien Pyr dit Ruys, Didier Vertommen, Mark H. Rider, Claire E. Eyers, Christopher G. Proud
Abstract: Eukaryotic elongation factor 2 kinase (eEF2K), an atypical calmodulin-dependent protein kinase, phosphorylates and inhibits eEF2, slowing down translation elongation. eEF2K contains an N-terminal catalytic domain, a C-terminal α-helical region and a linker containing several regulatory phosphorylation sites. eEF2K is expressed at high levels in certain cancers, where it may act to help cell survival, e.g., during nutrient starvation. However, it is a negative regulator of protein synthesis and thus cell growth, suggesting that cancer cells may possess mechanisms to inhibit eEF2K under good growth conditions, to allow protein synthesis to proceed. We show here that the mTORC1 pathway and the oncogenic Ras/Raf/MEK/extracellular signal-regulated kinase (ERK) pathway cooperate to restrict eEF2K activity. We identify multiple sites in eEF2K whose phosphorylation is regulated by mTORC1 and/or ERK, including new ones in the linker region. We demonstrate that certain sites are phosphorylated directly by mTOR or ERK. Our data reveal that glycogen synthase kinase 3 signaling also regulates eEF2 phosphorylation. In addition, we show that phosphorylation sites remote from the N-terminal calmodulin-binding motif regulate the phosphorylation of N-terminal sites that control CaM binding. Mutations in the former sites, which occur in cancer cells, cause the activation of eEF2K. eEF2K is thus regulated by a network of oncogenic signaling pathways.
Keywords: Eukaryotic elongation factor 2 kinase (eEF2K)
Rights: Copyright © 2014, American Society for Microbiology. All Rights Reserved.
DOI: 10.1128/MCB.01035-14
Appears in Collections:Aurora harvest 7
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.